Skip to main content

IlluminOss photodynamic bone stabilization system improves pain and function in the treatment of humeral metastatic disease.

Publication ,  Journal Article
Terek, RM; IlluminOss Study Group; McGough, R; Fabbri, N; Cheung, F; Brigman, B; Wittig, J; Emory, C; Aboulafia, A; Avedian, R; Mayerson, J ...
Published in: Bone Joint J
December 1, 2024

AIMS: The aim of the LightFix Trial was to evaluate the clinical outcomes for one year after the treatment of impending and completed pathological fractures of the humerus using the IlluminOss System (IS), and to analyze the performance of this device. METHODS: A total of 81 patients with an impending or completed pathological fracture were enrolled in a multicentre, open label single cohort study and treated with IS. Inclusion criteria were visual analogue scale (VAS) Pain Scores > 60 mm/100 mm and Mirels' Score ≥ 8. VAS pain, Musculoskeletal Tumor Society (MSTS) Upper Limb Function, and The European Organization for Research and Treatment of Cancer QoL Group Bone Metastases Module (QLQ-BM22) scores were all normalized to 100, and radiographs were obtained at baseline and at 14, 30, 90, 180, and 360 days postoperatively. RESULTS: The mean VAS pain score decreased significantly from 84 (SD 15) to 50 (SD 29), 38 (SD 30), 31 (SD 29), 31 (SD 29), and 21 (SD 23) between the baseline and follow-up times (p < 0.001). The mean MSTS function scores significantly increased from 27 (SD 19) to 52 (SD 22), 60 (23), 67 (SD 23), 72 (SD 26), and 83 (SD 14) (p < 0.001). The pain and functional subscales of the QLQ-BM22 also significantly improved at most times. A total of 12 devices broke, giving an unadjusted device fracture rate of 15%. CONCLUSION: Stabilization with the IS decreased pain and improved function with consistent results during the first postoperative year. IS is a new, minimally invasive type of internal fixation. The use of the IS alone may be better for impending rather than completed pathological fractures, and may be better in completed fractures if an added plate or more than the usual number of locking screws is required. Caution is warranted regarding its use alone in patients with a completed pathological fracture due to the rate of breakage of the device.

Duke Scholars

Published In

Bone Joint J

DOI

EISSN

2049-4408

Publication Date

December 1, 2024

Volume

106-B

Issue

12

Start / End Page

1485 / 1492

Location

England

Related Subject Headings

  • Treatment Outcome
  • Photochemotherapy
  • Pain Measurement
  • Middle Aged
  • Male
  • Humeral Fractures
  • Humans
  • Fractures, Spontaneous
  • Female
  • Bone Neoplasms
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Terek, R. M., IlluminOss Study Group, McGough, R., Fabbri, N., Cheung, F., Brigman, B., … Adams, B. (2024). IlluminOss photodynamic bone stabilization system improves pain and function in the treatment of humeral metastatic disease. Bone Joint J, 106-B(12), 1485–1492. https://doi.org/10.1302/0301-620X.106B12.BJJ-2023-1089.R2
Terek, Richard M., IlluminOss Study Group, Richard McGough, Nicola Fabbri, Felix Cheung, Brian Brigman, James Wittig, et al. “IlluminOss photodynamic bone stabilization system improves pain and function in the treatment of humeral metastatic disease.Bone Joint J 106-B, no. 12 (December 1, 2024): 1485–92. https://doi.org/10.1302/0301-620X.106B12.BJJ-2023-1089.R2.
Terek RM, IlluminOss Study Group, McGough R, Fabbri N, Cheung F, Brigman B, et al. IlluminOss photodynamic bone stabilization system improves pain and function in the treatment of humeral metastatic disease. Bone Joint J. 2024 Dec 1;106-B(12):1485–92.
Terek, Richard M., et al. “IlluminOss photodynamic bone stabilization system improves pain and function in the treatment of humeral metastatic disease.Bone Joint J, vol. 106-B, no. 12, Dec. 2024, pp. 1485–92. Pubmed, doi:10.1302/0301-620X.106B12.BJJ-2023-1089.R2.
Terek RM, IlluminOss Study Group, McGough R, Fabbri N, Cheung F, Brigman B, Wittig J, Emory C, Aboulafia A, Avedian R, Mayerson J, Henshaw R, Reimer N, Eward W, Weiss K, Healey J, Mohler D, Adams B. IlluminOss photodynamic bone stabilization system improves pain and function in the treatment of humeral metastatic disease. Bone Joint J. 2024 Dec 1;106-B(12):1485–1492.

Published In

Bone Joint J

DOI

EISSN

2049-4408

Publication Date

December 1, 2024

Volume

106-B

Issue

12

Start / End Page

1485 / 1492

Location

England

Related Subject Headings

  • Treatment Outcome
  • Photochemotherapy
  • Pain Measurement
  • Middle Aged
  • Male
  • Humeral Fractures
  • Humans
  • Fractures, Spontaneous
  • Female
  • Bone Neoplasms